Literature DB >> 25611491

Classification of CEBPA mutated acute myeloid leukemia by GATA2 mutations.

Alice Marceau-Renaut1, Soizic Guihard, Sylvie Castaigne, Hervé Dombret, Claude Preudhomme, Meyling Cheok.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25611491     DOI： 10.1002/ajh.23949

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  4 in total

1.  Differential effects on gene transcription and hematopoietic differentiation correlate with GATA2 mutant disease phenotypes.

Authors:  C-E Chong; P Venugopal; P H Stokes; Y K Lee; P J Brautigan; D T O Yeung; M Babic; G A Engler; S W Lane; M Klingler-Hoffmann; J M Matthews; R J D'Andrea; A L Brown; C N Hahn; H S Scott
Journal:  Leukemia       Date:  2017-06-23       Impact factor: 11.528

2.  GATA2 zinc finger 1 mutations are associated with distinct clinico-biological features and outcomes different from GATA2 zinc finger 2 mutations in adult acute myeloid leukemia.

Authors:  Feng-Ming Tien; Hsin-An Hou; Cheng-Hong Tsai; Jih-Luh Tang; Yu-Chiao Chiu; Chien-Yuan Chen; Yuan-Yeh Kuo; Mei-Hsuan Tseng; Yen-Ling Peng; Ming-Chih Liu; Chia-Wen Liu; Xiu-Wen Liao; Liang-In Lin; Chien-Ting Lin; Shang-Ju Wu; Bor-Sheng Ko; Szu-Chun Hsu; Shang-Yi Huang; Ming Yao; Wen-Chien Chou; Hwei-Fang Tien
Journal:  Blood Cancer J       Date:  2018-08-31       Impact factor: 11.037

3.  Molecular Profiling Defines Distinct Prognostic Subgroups in Childhood AML: A Report From the French ELAM02 Study Group.

Authors:  Alice Marceau-Renaut; Nicolas Duployez; Benoît Ducourneau; Myriam Labopin; Arnaud Petit; Alexandra Rousseau; Sandrine Geffroy; Maxime Bucci; Wendy Cuccuini; Odile Fenneteau; Philippe Ruminy; Brigitte Nelken; Stéphane Ducassou; Virginie Gandemer; Thierry Leblanc; Gérard Michel; Yves Bertrand; André Baruchel; Guy Leverger; Claude Preudhomme; Hélène Lapillonne
Journal:  Hemasphere       Date:  2018-02-21

Review 4.  Acute Myeloid Leukemia With CEBPA Mutations: Current Progress and Future Directions.

Authors:  Long Su; Yuan-Yuan Shi; Zeng-Yan Liu; Su-Jun Gao
Journal:  Front Oncol       Date:  2022-02-01       Impact factor: 6.244
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.